What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Teva Pharmaceutical Industries Ltd. ADR, TEVA Quick Chart - (NYS) TEVA, Teva Pharmaceutical Industries Ltd. ADR Stock Price - BigCharts.com
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Israel stocks ease; Teva loses patent ruling - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
U.S. court rules for Teva in migraine patent dispute with Eli Lilly
Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic Group - The Economic Times
Israeli stocks rise; Brainsway, Ratio Oil off - MarketWatch
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Israel stocks steady; Teva settles with Takeda - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Teva to buy Allergan generics for $40.5 billion - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Opinion: These 3 stocks may be the only true value plays left - MarketWatch
Teva in talks to buy Allergan's generics unit - MarketWatch
Israel stocks rise as investors key on Teva, ICL - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Opinion: Multinationals learn the limits of being big - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Israel stocks fall for fifth day; Teva rises - MarketWatch
